Blog

Close to half of Maine’s medical cannabis may contain pesticides, mold, officials say

| October 05, 2023

By Hannah LaClaire for the Portland Press Herald Steph Sherer, founder of medical cannabis advocacy group Americans for Safe Access, stressed during the panel Tuesday that contaminants are often an innocent mistake.“It doesn’t mean that there’s someone who has some...

Read more

Marijuana lab testing under scrutiny amid recalls, differing rules

Marijuana Business Daily (MJ Biz Daily) | October 05, 2023

By Kate Robertson for MJBizDaily State marijuana regulators, producers and other stakeholders are grappling with how to safeguard consumers at a time when lab-testing requirements and enforcement differ dramatically nationwide and large-scale product recalls are common. Each state currently takes...

Read more

I Found a Vape Pen at My Son’s School. Finding Out What Was Inside Was a Lot Harder.

| September 14, 2023

By Doug Henry for Mother Jones One seller claims Gold Coast Clear is “working hard to keep their customers safe,” and that “these verified cartridges have undergone various lab tests approved by CannaSafe.” Of course, that language doesn’t say they...

Read more

SCHEDULE III Fears, Facts & the Future

Steph Sherer | September 13, 2023

Navigating Medical Cannabis in the Federal Arena The news of Health and Human Services’ (HHS) recommendation to move Cannabis to a Schedule III status created a flurry of media coverage and press statements from various cannabis stakeholders and elected officials...

Read more

Shifting Tides: US Department of Health and Human Services Recommends Cannabis Rescheduling from Schedule I to Schedule III

| September 01, 2023

By Madeline Colli, Erin McEvoy for Cannabis Science and Technology On Wednesday, August 30th, the Department of Health and Human Services made its recommendation to the Drug Enforcement Agency to classify cannabis as a Schedule III drug, paving the way...

Read more

FDA JUST UNLOCKED A DOOR FOR CANNABIS POLICY, WILL CONGRESS PUSH IT OPEN?

Steph Sherer | August 31, 2023

What just Happened On Wednesday, Bloomberg news reported that Health and Human Services (HHS) is recommending that cannabis be rescheduled to Schedule III following the Food and Drug Administration’s (FDA) scientific review of cannabis under the direction of President Biden....

Read more

Prioritize Consumer Safety: Our response to a Congressional Request for Information on Federal Cannabinoid Hemp Regulation

Steph Sherer | August 22, 2023

Last week, Americans for Safe Access responded to a bicameral Congressional Request for Information on cannabinoid hemp regulation from the U.S. House Committee on Energy & Commerce and the U.S. Senate Committee on Health, Education, Labor, and Pensions.

Read more

Want to work in Maryland’s cannabis industry? There are classes and degrees for that.

| August 18, 2023

By Meredith Cohn for The Baltimore Banner “Most other programs around the country, as far as I know, are focused on professional skill development for working in the cannabis industry, but not so much on cannabis as a medicine. I...

Read more

Marijuana Groups Push Regulators To Adopt Universal Label For Cannabis Products To Facilitate Interstate Commerce And Promote Safety

Kyle Jaeger | August 18, 2023

By Kyle Jaeger for Marijuana Moment A coalition of marijuana reform organizations are calling on regulators across the world to adopt a universal symbol for marijuana products in the interest of promoting safety in the evolving cannabis market and making...

Read more

WHILE CONGRESS IS TAKING THEIR AUGUST RECESS, LET’S RESET OUR COMMITMENT TO MEDICAL CANNABIS ADVOCACY

Steph Sherer | August 14, 2023

Let’s be honest, medical cannabis is not the most pressing issue in Washington these days. I have experienced firsthand from walking the halls of Congress, that while a majority of members are sympathetic to the needs of patients, most do...

Read more